Viewbix Completes Strategic Acquisition of Quantum X Labs – Securing Advanced Quantum Portfolio

Rhea-AI Summary

Viewbix (NASDAQ: VBIX) completed the acquisition of 100% of Quantum X Labs on March 4, 2026, acquiring a proprietary IP portfolio that includes an AI-Quantum Error Correction patent and capabilities in quantum navigation, atomic clocks, and quantum algorithms.

The company issued common stock and pre-funded warrants representing approximately 40% of its capital stock as of the December 15, 2025 agreement date, and may issue up to 12,702,847 additional shares or pre-funded warrants upon achievement of milestones. Viewbix also closed a private placement raising approximately $1.4 million (800,000 shares at $1.75 plus 640,000 warrants exercisable at $2.625).

Positive

• Acquired 100% of Quantum X Labs and its proprietary IP, including AI-Quantum Error Correction
• Adds capabilities in quantum navigation, next-generation atomic clocks, and quantum algorithms
• Closed private placement raising approximately $1.4M to support working capital

Negative

• Issued equity and pre-funded warrants representing ~40% of capital stock as of Agreement Date (dilution)
• Potential issuance of up to 12,702,847 additional shares or pre-funded warrants upon milestones (further dilution risk)
• Issued 640,000 exercisable warrants and unregistered securities, limiting immediate liquidity for those shares

News Market Reaction – VBIX

+16.13% 93.6x vol

16 alerts

+16.13% News Effect

+15.2% Peak Tracked

-39.0% Trough Tracked

+$3M Valuation Impact

$19M Market Cap

93.6x Rel. Volume

On the day this news was published, VBIX gained 16.13%, reflecting a significant positive market reaction. Argus tracked a peak move of +15.2% during that session. Argus tracked a trough of -39.0% from its starting point during tracking. Our momentum scanner triggered 16 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $3M to the company's valuation, bringing the market cap to $19M at that time. Trading volume was exceptionally heavy at 93.6x the daily average, suggesting very strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Quantum stake acquired: 100% of Quantum X Labs Equity issued at closing: ≈40% of capital stock Milestone consideration: Up to 12,702,847 shares/warrants +5 more

8 metrics

Quantum stake acquired 100% of Quantum X Labs Acquisition completed March 4, 2026

Equity issued at closing ≈40% of capital stock Common stock and pre-funded warrants as of Agreement Date

Milestone consideration Up to 12,702,847 shares/warrants Contingent on post-closing milestones

Private placement shares 800,000 common shares Issued at $1.75 per share

Private placement warrants 640,000 common warrants Each for 1 share, exercisable at $2.625

Exercise price $2.625 per share Common warrants issued in private placement

Gross proceeds ≈$1.4 million Aggregate gross proceeds from private placement

Warrant term 5 years Common warrants exercisable upon issuance

Market Reality Check

Price: $1.72 Vol: Volume 21,595 vs 20-day a...

high vol

$1.72 Last Close

Volume Volume 21,595 vs 20-day average 12,061 indicates elevated trading ahead of this acquisition update. high

Technical Shares at $1.69 are trading below the $3.08 200-day moving average and far under the $9.80 52-week high.

Peers on Argus

VBIX was down 3.98% while peers were mixed: SCOR +5.37%, FENG +2.34%, GIFT -6.57...

VBIX was down 3.98% while peers were mixed: SCOR +5.37%, FENG +2.34%, GIFT -6.57%, SJ -3.68%, ZDGE +0.32%, suggesting stock-specific dynamics.

Common Catalyst Select peers also had news (AI and media partnerships), but no shared acquisition or financing theme with VBIX.

Previous Acquisition Reports

5 past events · Latest: Mar 04 (Positive)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 04	Acquisition closing	Positive	-4.0%	Completion of 100% Quantum X Labs acquisition and related equity issuance.
Feb 23	Acquisition review	Positive	-1.8%	Strategic review article on Quantum X Labs deal terms and financing.
Jan 08	Acquisition agreement	Positive	-3.5%	Details on agreement to acquire 85–100% of Quantum X Labs and earn-outs.
Jan 05	Stockholder approval	Positive	+4.3%	Stockholder consent for Quantum X Labs acquisition and share issuances.
Dec 16	Definitive agreement	Positive	-24.8%	Signing of definitive agreement to acquire Quantum X Labs with large equity payout.

Pattern Detected

Acquisition-related announcements for Quantum X Labs have often coincided with negative next-day moves, despite strategic framing.

Recent Company History

Over recent months, Viewbix has repeatedly updated investors on its acquisition of Quantum X Labs, moving from a definitive agreement on Dec 15, 2025 through stockholder approval on Jan 5, 2026 to closing on March 4, 2026. These steps involved issuing stock and pre-funded warrants equal to about 40% of capital and potential earn-outs up to 12,702,847 shares or warrants. Price reactions to these acquisition milestones have skewed negative, underscoring market sensitivity to equity dilution.

Historical Comparison

-6.0% avg move · Past Quantum X Labs acquisition headlines saw an average move of -5.95%. The current -3.98% pre-news...

acquisition

-6.0%

Average Historical Move acquisition

Past Quantum X Labs acquisition headlines saw an average move of -5.95%. The current -3.98% pre-news move sits within that negative skew, consistent with prior dilution-sensitive reactions.

Acquisition news progressed from initial term sheets and definitive agreements in late 2025, through stockholder approval in early 2026, to full closing and integration of Quantum X Labs’ IP and portfolio companies.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-08-05

Viewbix has an active S-3 shelf filed on 2025-08-05 expiring on 2028-08-05. It is not yet effective and shows 0 recorded usages in the provided data, indicating capacity remains available for future registered financings once effective.

Market Pulse Summary

The stock surged +16.1% in the session following this news. A strong positive reaction aligns with t...

Analysis

The stock surged +16.1% in the session following this news. A strong positive reaction aligns with the strategic nature of acquiring 100% of Quantum X Labs and securing its AI-quantum error correction IP, while locking in $1.4 million in fresh capital. Historically, however, Quantum-related acquisition headlines averaged about -5.95%, reflecting concern over sizable equity issuance and future earn-out shares. Any sustained strength would have to contend with this track record and the company’s unused shelf registration, which allows additional capital raising once effective.

Key Terms

pre-funded warrants, common warrants, exercise price, private placement, +1 more

5 terms

pre-funded warrants financial

"Viewbix issued common stock and pre-funded warrants representing approximately 40% of its capital"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

common warrants financial

"the Company issued an aggregate of 640,000 common warrants, each exercisable for one share"

A common warrant is a tradable instrument that gives its holder the right to buy a company’s common shares at a fixed price within a set time period, similar to a coupon that can be redeemed later to purchase stock. Investors care because exercising warrants can boost potential gains if the stock rises, but it can also dilute existing shareholders by increasing the number of shares outstanding, which can lower per-share value.

exercise price financial

"common warrants, each exercisable for one share of common stock, at an exercise price of $2.625 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

private placement financial

"Viewbix also closed a private placement of approximately $1.4 million shares of the Company’s common stock"

A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.

accredited investors regulatory

"The securities were offered only to accredited investors."

Accredited investors are individuals or entities considered to have enough financial knowledge and resources to understand and handle more complex and risky investments. They are often allowed to participate in private investment opportunities that are not available to the general public, similar to how experienced players might access exclusive clubs or events. This status helps ensure that investors can manage potential risks and rewards appropriately.

AI-generated analysis. Not financial advice.

Tel Aviv, Israel, March 05, 2026 (GLOBE NEWSWIRE) -- The acquisition encompasses Quantum’s proprietary intellectual property portfolio, including an innovative patent for AI-Quantum Error Correction

Tel Aviv, Israel, March 5, 2026, (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), an advanced technologies company, recently announced that it has completed the acquisition of 100% of Quantum X Labs Ltd. (“Quantum”), a multi-disciplinary quantum technology hub focused on quantum algorithms, navigation, and atomic clocks, pursuant to the definitive share purchase agreement dated December 15, 2025 (the “Agreement Date”).

The acquisition encompasses Quantum’s proprietary intellectual property portfolio, including an innovative patent for AI-Quantum Error Correction.

Quantum operates portfolio companies developing innovative solutions in quantum-based navigation (including GPS alternatives), next-generation atomic clocks for precision timing, quantum algorithms for sectors such as transportation, drug discovery, biomedicine, and security, as well as advanced quantum error correction technologies.

In connection with the closing, Viewbix issued common stock and pre-funded warrants representing approximately 40% of its capital stock as of the Agreement Date (inclusive of 800,000 shares of common stock issued in a related private placement), with potential additional consideration of up to 12,702,847 shares of the Company’s common stock or pre-funded warrants upon achievement of specified post-closing milestones.

In addition to the closing of the Quantum acquisition, Viewbix also closed a private placement of approximately $1.4 million shares of the Company’s common stock and warrants to purchase common stock.

In connection with the private placement, the Company issued an aggregate of 800,000 shares of common stock at a price of $1.75 per share. In addition, the Company issued an aggregate of 640,000 common warrants, each exercisable for one share of common stock, at an exercise price of $2.625 per share to the investors in the private placement for no additional consideration. The common warrants are exercisable upon issuance and have a term of 5 years from the issuance date.

Aggregate gross proceeds to the Company were approximately $1.4 million, before deducting offering expenses payable by the Company. The Company expects to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital.

The closing of the Quantum acquisition and private placement occurred on March 4, 2026. 

The securities described above were issued and/or sold in private placement transactions not involving a public offering and exempt from the registration requirements of the Securities Act of 1933, as amended (the "Act"), and have not been registered under the Act, or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws. The securities were offered only to accredited investors.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Viewbix Inc.

Viewbix, through certain of its subsidiaries Gix Media Ltd. and Metagramm Software Ltd., operates in the field of digital advertising. Gix Media develops a variety of technological software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of acquiring and routing internet user traffic to its customers. Metagramm is a developer of grammatical error correction software. The company offers tools for writing and reviewing, grammar, spelling, punctuation and style features, as well as translation and multilingual dictionaries, using artificial intelligence and machine learning technology.

For more information about Viewbix, visit https://view-bix.com/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the achievement of specified post-closing milestones and the intended use of proceeds from the private placement. Because such statements deal with future events and are based on Viewbix’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Viewbix undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Viewbix is not responsible for the contents of third-party websites.

Investor Relations Contacts:
Michal Efraty
Investor Relations
michal@efraty.com

FAQ

What did Viewbix (VBIX) acquire from Quantum X Labs on March 4, 2026?

Viewbix acquired 100% ownership of Quantum X Labs, including its IP portfolio. According to the company, the purchase includes an AI-Quantum Error Correction patent and capabilities in quantum navigation, atomic clocks, and quantum algorithms.

How much equity did Viewbix issue as part of the Quantum X Labs acquisition (VBIX)?

Viewbix issued common stock and pre-funded warrants representing approximately 40% of its capital stock as of the agreement date. According to the company, that figure is inclusive of 800,000 shares issued in a related private placement.

What are the contingent payments tied to the Quantum acquisition for VBIX shareholders?

The acquisition includes potential additional consideration of up to 12,702,847 shares or pre-funded warrants upon achieving specified post-closing milestones. According to the company, those issuances are milestone-dependent and not yet triggered.

What were the terms and proceeds of Viewbix's private placement related to the acquisition (VBIX)?

Viewbix sold 800,000 shares at $1.75 and issued 640,000 warrants exercisable at $2.625, raising approximately $1.4 million gross. According to the company, proceeds are intended for general corporate purposes and working capital.

When did Viewbix complete the Quantum X Labs acquisition and are the securities registered (VBIX)?

The company completed the acquisition and private placement closing on March 4, 2026. According to the company, the securities were issued in private placements exempt from registration and were offered only to accredited investors.